🚀 VC round data is live in beta, check it out!
Luyan Pharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for Luyan Pharma and similar public comparables like Pague Menos, Genky Drug Stores, Shu Yu Civilian Pharmacy, Zjamp Group and more.
Luyan Pharma Overview
About Luyan Pharma
Luyan Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.
Founded
2008
HQ
Employees
5.6K
Website
Sectors
Financials (FY)
EV
$2B
Luyan Pharma Financials
Luyan Pharma reported last fiscal year revenue of $3B and EBITDA of $115M.
In the same fiscal year, Luyan Pharma generated $221M in gross profit, $115M in EBITDA, and $50M in net income.
Luyan Pharma P&L
In the most recent fiscal year, Luyan Pharma reported revenue of $3B and EBITDA of $115M.
Luyan Pharma expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $221M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 7% | XXX | XXX | XXX |
| EBITDA | — | XXX | $115M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 4% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 3% | XXX | XXX | XXX |
| Net Profit | — | XXX | $50M | XXX | XXX | XXX |
| Net Margin | — | XXX | 2% | XXX | XXX | XXX |
| Net Debt | — | — | $573M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Luyan Pharma Stock Performance
Luyan Pharma has current market cap of $864M, and enterprise value of $2B.
Market Cap Evolution
Luyan Pharma's stock price is $2.22.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $864M | 1.0% | XXX | XXX | XXX | $0.13 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLuyan Pharma Valuation Multiples
Luyan Pharma trades at 0.5x EV/Revenue multiple, and 13.2x EV/EBITDA.
Luyan Pharma Financial Valuation Multiples
As of March 19, 2026, Luyan Pharma has market cap of $864M and EV of $2B.
Equity research analysts estimate Luyan Pharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Luyan Pharma has a P/E ratio of 17.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $864M | XXX | $864M | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 13.2x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 15.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 6.9x | XXX | XXX | XXX |
| P/E | — | XXX | 17.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 48.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Luyan Pharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Luyan Pharma Margins & Growth Rates
Luyan Pharma's revenue in the last fiscal year grew by 3%.
Luyan Pharma Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (3%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 4% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Luyan Pharma Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Genky Drug Stores | XXX | XXX | XXX | XXX | XXX | XXX |
| Shu Yu Civilian Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Zjamp Group | XXX | XXX | XXX | XXX | XXX | XXX |
| GoodRx | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Luyan Pharma M&A Activity
Luyan Pharma acquired XXX companies to date.
Last acquisition by Luyan Pharma was on XXXXXXXX, XXXXX. Luyan Pharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Luyan Pharma
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLuyan Pharma Investment Activity
Luyan Pharma invested in XXX companies to date.
Luyan Pharma made its latest investment on XXXXXXXX, XXXXX. Luyan Pharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Luyan Pharma
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Luyan Pharma
| When was Luyan Pharma founded? | Luyan Pharma was founded in 2008. |
| Where is Luyan Pharma headquartered? | Luyan Pharma is headquartered in China. |
| How many employees does Luyan Pharma have? | As of today, Luyan Pharma has over 5K employees. |
| Is Luyan Pharma publicly listed? | Yes, Luyan Pharma is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Luyan Pharma? | Luyan Pharma trades under 002788 ticker. |
| When did Luyan Pharma go public? | Luyan Pharma went public in 2016. |
| Who are competitors of Luyan Pharma? | Luyan Pharma main competitors are Pague Menos, Genky Drug Stores, Shu Yu Civilian Pharmacy, Zjamp Group. |
| What is the current market cap of Luyan Pharma? | Luyan Pharma's current market cap is $864M. |
| What is the current revenue of Luyan Pharma? | Luyan Pharma's last fiscal year revenue is $3B. |
| What is the current EV/Revenue multiple of Luyan Pharma? | Current revenue multiple of Luyan Pharma is 0.5x. |
| Is Luyan Pharma profitable? | No, Luyan Pharma is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.